Marketed as a "powerful stimulant", kamini tablets cause lead poisoning in individual, Australia issues urgent health warningA hospitalization in South Australia unveiled severe lead poisoning from Kamini tablets, sold as vitality boosters at a Southeast Asian sup...
How to tell if your Covid rapid antigen test can actually detect OmicronRATs diagnose Covid infection by detecting specific viral proteins.
Australia 'recognises' Bharat Biotech's CovaxinAustralia has officially recognised Bharat Biotech's Covid-19 vaccine Covaxin for the purpose of establishing a traveller's vaccination sta...
Australia to continue AstraZeneca vaccination despite blood clotting caseA 44-year-old man was admitted to a Melbourne hospital with clotting, days after receiving the AstraZeneca vaccine, suffering serious throm...
Batches of Strides' Ranitidine tablets now available for sale in AustraliaOut of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limi...
Jubilant Life arm gets Australia TGA nod for lung scan drugJubilant Pharma, through one of its units JDI, has received approval from TGA, Australia, for Lyophilized kit for preparation of Technetium...
Venus Remedies to sell Meropenem in Australia; ties up with LupinVenus Remedies said it plans to roll out the drug by the third quarter of 2014 and is eyeing sizeable share in Australia's USD 15 million M...
- Venus receives nod for four plants from Australian authority
Venus Remedies has received approval from Australian authorities for 4 of its facilities, thus enabling the company to export products from...
- Ind Swift Lab gets Australia's nod for its Dera Bassi plant
Drug firm Ind Swift said it has received approval from the Australian health regulator to make seven active pharmaceutical ingredients.
- Aurobindo receives Australia nod for schizophrenia, osteoporosis drugs
Aurobindo Pharma has received approval from the Australian health authority to market Risperidone and Alendronate tablets.
- Aussie nod for Ranbaxy's anti-psychotic drug
Ranbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...
- Ranbaxy gets Australia nod for antipsychotic drug
Ranbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...
- Reliance Money upgrades Ranbaxy to ‘BUY’; target price Rs 189
Given the attractive valuations at current levels, Reliance Money has upgraded its rating on Ranbaxy Laboratories from ‘hold’ to ‘buy’ with...
- Ranbaxy gets approval to market anti-fungal drugs in Australia
Drug major Ranbaxy Laboratories said it has received approval from Australian health regulator to market its anti-fungal tablets Serbifin T...
- Aussie regulator puts Ranbaxy under scanner
The Australian drug regulator Therapeutic Goods Administration (TGA) said it is reviewing 62 drugs sold in the country which are made by Ra...
- Australia reviews Ranbaxy drugs
The Australian drug regulator Therapeutic Goods Administration(TGA) said it is reviewing 62 drugs sold in the country which are made by Ran...
- Aurobindo gets Australia nod for anti-hypertension drugs
Drug maker Aurobindo Pharma said on Monday that its Australian subsidiary has received approval from the government agency for registering ...